|
|
Post by promann on Sept 20, 2017 12:24:33 GMT -5
Can't go by that at all. Sanofi was running things and by this time in 2015 they probably already knew they were going to return Afrezza to MNKD. You can see on the graphs where the sales peaked and started to drop before this time in 2015 because they quit trying to sell the drug. i hope your wrong but we shall see. Inappropriately, can you image a conversation, that of course/coarse never took place? Sanofi, Lilly, and Novo Nordisk in a room. "We have a new insulin coming on the market, it is inhaled. The thing about this insulin is it enters the blood stream immediately through the alveoli." "What would that mean for blood glucose control?" "It may be a better blood glucose management tool than the delivery system our businesses are set up on." "It will effect our profit centers if this medication succeeds." "What are the chances it will succeed?" "Perhaps we should nip this flower at the bud? Protect our profits." "How would we do that?" money to work with. "This medication has no formulary status, and the company doesn't have much money to work with. They are looking for a partner." "One of us could partner with them and then we would have control." "That isn't a bad idea." "To be fair, we need to draw straws." The straws are brought out and drawn. Sanofi drew the short straw. "We know how to do this, we have the exubera model." "Enough said. Good work gentlemen."
I am so inappropriate.
Hey pep, I don't think your very far off here. nice analogy sounds almost plausible. |
|
|
|
Post by kc on Sept 20, 2017 12:47:49 GMT -5
Came across this today on Fidelity.
UPC Restricted (Yes)
Not sure what this really means but Luigi thought it had to so with short positions as outlined on this link. UPC 11830
en.termwiki.com/EN/UPC-11830
UPC-11830
In 1993, the U.S. Securities and Exchange Commission approved a new section of the Uniform Practice Code (UPC) requiring FINRA members to close out short sales in NASDAQ® securities that meet a certain clearing short position threshold. Both NASDAQ National Market® and NASDAQ Small Cap Market securities can be restricted under UPC 11830. Under the rules, the short seller's broker/dealer must close out short sale of specific securities 10 days after normal settlement date if delivery of security has not accrued and the transaction is not exempt. Securities subject to close-out requirement are those with an aggregate "clearing" short position of 10,000 shares or more that equals or exceeds one half of one percent of the total shares outstanding. The FINRA will identify these securities daily based on data from National Securities and Clearing Corporation and compile a "restricted list." Any subsequent short-sale transaction in a security on the list that is not completed by delivery of shares within the prescribed time frames will be subject to mandatory close-out if a "fail-to-deliver" situation exists 10 days after normal settlement date.
The rule applies to customer and proprietary short sales, but exempts "bona fide" market making activities and short sales that results in a "bona fide" fully hedged or arbitraged position. For more information, please see FINRA Notice to Members 93-53.
|
|
|
|
Post by peppy on Sept 20, 2017 13:39:58 GMT -5
MNKD steady as she goes with the fed rate decision market sell off.
1,270,146 shares traded with 1 1/2 hours of regular trade left.
the volume at 2 hours was over a million. You can see how the volume slowed.
$2.03 plus 1 cent. Yellen outlining the fed balance sheet normalization program. How many billion per month will be removed. The balance sheet still needs to be normalized after the banking crisis.
Heh 3 trillion printed, qualitative easing.
|
|
|
|
Post by dreamboatcruise on Sept 20, 2017 14:49:35 GMT -5
MNKD real time nasdaq volume today, 3,085,176 shares. 3% of shares outstanding. $2.02. down 26 cents down 11.4% www.nasdaq.com/symbol/mnkd/real-time
MNKD Nasdaq summation volume, 4,122,902 shares. www.nasdaq.com/symbol/mnkd
trading took out most of last weeks gains. the 200 day sma $1.96 and the 20 day $1.91 below
a daily with exponential moving averages schrts.co/iPmh3e the 200 day ema $2.22 the 20 day ema $1.94
So which of all of these moving averages (or something else) is most important for us to stay above in order to avoid a more serious breakdown from having technical driven traders piling in against us? |
|
|
|
Post by peppy on Sept 20, 2017 15:05:44 GMT -5
MNKD real time nasdaq volume today, 3,085,176 shares. 3% of shares outstanding. $2.02. down 26 cents down 11.4% www.nasdaq.com/symbol/mnkd/real-time
MNKD Nasdaq summation volume, 4,122,902 shares. www.nasdaq.com/symbol/mnkd
trading took out most of last weeks gains. the 200 day sma $1.96 and the 20 day $1.91 below
a daily with exponential moving averages schrts.co/iPmh3e the 200 day ema $2.22 the 20 day ema $1.94
So which of all of these moving averages (or something else) is most important for us to stay above in order to avoid a more serious breakdown from having technical driven traders piling in against us? Do you see it dreamboat? Can you read it? Tell me what you think, and I will tell you what I see.
|
|
|
|
Post by kbrion77 on Sept 20, 2017 15:10:05 GMT -5
We were told by Mike at the Q2 earnings call he would be holding two investor updates. Time is running short if they give a few days notice in a press release. I wouldn't think they would hold 2 updates in the same week.
|
|
|
|
Post by peppy on Sept 20, 2017 15:10:25 GMT -5
|
|
|
|
Post by peppy on Sept 20, 2017 15:11:55 GMT -5
We were told by Mike at the Q2 earnings call he would be holding two investor updates. Time is running short if they give a few days notice in a press release. I wouldn't think they would hold 2 updates in the same week. investors.mannkindcorp.com/events.cfm
monday
|
|
|
|
Post by dreamboatcruise on Sept 20, 2017 15:15:28 GMT -5
peppy... apparently my reading glasses don't have the right coating on them, it seems kinda fuzzy to me  I'll be the first to admit I know little about TA. I see that there was a tightening range you have marked with lines that were converging and then we solidly broke out to the upside. Not sure what the significance of breaking back below the upper one of those would be. If we broke the lower I would think very bad, but that is much, much lower than where we are, and you didn't even extend that line to present so I assume you don't consider that as in play or relevant. Do you have a recommendation on a good tutorial on the basics of chart reading?
|
|
|
|
Post by peppy on Sept 20, 2017 15:18:48 GMT -5
peppy ... apparently my reading glasses don't have the right coating on them, it seems kinda fuzzy to me I'll be the first to admit I know little about TA. I see that there was a tightening range you have marked with lines that were converging and then we solidly broke out to the upside. Not sure what the significance of breaking back below the upper one of those would be. If we broke the lower I would think very bad, but that is much, much lower than where we are, and you didn't even extend that line to present so I assume you don't consider that as in play or relevant. Do you have a recommendation on a good tutorial on the basics of chart reading? I will make it short and easy. you see that 20 week sma? it is sitting at the downtrend line that price finally made it out of.
The caveat, Oct 31 is 41 days away.
The daily chart. schrts.co/9Lk2Sw
|
|
|
|
Post by dreamboatcruise on Sept 20, 2017 16:58:22 GMT -5
peppy... now I see. So over the long term from a chart perspective it would be good if the 20 week sma breaks and stays above that downtrend line... bad if it briefly breaks above and then crosses down again? In the latter case you'd then redraw the downtrend taking into account the slight breach above and consider the new line as resistance? What about the shorter term chart? Let's say there is some person (or lizard) that is considering buying some more calls on the possibility of a positive recapitalization, and wants to try to catch a short term low over the next month. Are there any clues to how low we might go before there is news to change the situation... where we might have solid support?
|
|
|
|
Post by peppy on Sept 20, 2017 18:53:02 GMT -5
peppy ... now I see. So over the long term from a chart perspective it would be good if the 20 week sma breaks and stays above that downtrend line... bad if it briefly breaks above and then crosses down again? In the latter case you'd then redraw the downtrend taking into account the slight breach above and consider the new line as resistance? What about the shorter term chart? Let's say there is some person (or lizard) that is considering buying some more calls on the possibility of a positive recapitalization, and wants to try to catch a short term low over the next month. Are there any clues to how low we might go before there is news to change the situation... where we might have solid support? to answer your question, it looks like $1.50. That has to hold. the stop can be 6 cents below. schrts.co/JwneYb
with any luck this test the 20 and 200 day will hold and price will continue up.
such a fine insulin. Thank you vdex for figuring out dosing.
|
|
|
|
Post by dreamboatcruise on Sept 20, 2017 19:10:22 GMT -5
peppy ... now I see. So over the long term from a chart perspective it would be good if the 20 week sma breaks and stays above that downtrend line... bad if it briefly breaks above and then crosses down again? In the latter case you'd then redraw the downtrend taking into account the slight breach above and consider the new line as resistance? What about the shorter term chart? Let's say there is some person (or lizard) that is considering buying some more calls on the possibility of a positive recapitalization, and wants to try to catch a short term low over the next month. Are there any clues to how low we might go before there is news to change the situation... where we might have solid support? to answer your question, it looks like $1.50. That has to hold. the stop can be 6 cents below. schrts.co/JwneYb
with any luck this test the 20 and 200 day will hold and price will continue up.
such a fine insulin. Thank you vdex for figuring out dosing.
Thanks. I've really got more than enough already (wouldn't want to suffer from an embarrassment of riches in the future ), but if we continue down I'll pay attention around $1.5 with the eye of picking up some more calls if we seem to hold that line. Actually I'll be happy if we go up from here rather than giving me another buying opportunity. |
|
|
|
Post by peppy on Sept 21, 2017 19:16:48 GMT -5
|
|
|
|
Post by brotherm1 on Sept 21, 2017 19:28:28 GMT -5
The sad face says this is not good. But it seemed to me the 2.00 support is there, isn't it? should be, I hope so. the 200 day sma and 20 day sma are at $1.96 and $1.91 respectively. let's hope it is a test of the 200 day sma. the 200 day ema was the resistance at $2.22.
With selling volume slowing, perhaps we'll at least keep or go above this support going into Friday's scripts and ahead of Monday's Cantor Fitzgerald |
|
I'll be the first to admit I know little about TA.